Skip to main content
SpringerLink
Log in

Interferons as antitumor agents

  • Guest Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Brouty-Boye D, Gresser I (1981) Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T 1/2 cells under prolonged treatment with interferon. Int J Cancer 28:165–173

    Google Scholar 

  • DeMaeyer E, Galasso G, Schellekens H (eds) (1981) The biology of the interferon System. Elsevier, Amsterdam

    Google Scholar 

  • DeMaeyer E, DeMaeyer-Guignard J (1980) Host phenotype influences immunomodulation by interferon. Nature 284:173–175

    Google Scholar 

  • Derynck R, Content J, DeClerque E, Volckart G, Tavernier J, Davos R, Fiers W (1980) Isolation and structure of a human fibroblast interferon gene. Nature 285:542–546

    Google Scholar 

  • Fleischmann WR, Jr, Georgiades JA, Osborne LC, Johnson HM (1980) Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst 65:963–966

    Google Scholar 

  • Gidlund N, Oern A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759–761

    Google Scholar 

  • Gresser I (1978) Antitumor effects of interferon. Biochim Biophys Acta 516:231–247

    Google Scholar 

  • Gresser I, DeMaeyer-Guignard J, Tovey MG, DeMaeyer E (1979) Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci USA 76:5308–5312

    Google Scholar 

  • Hanley DF, Wiranowska-Stewart M, Stewart II WE (1979) Pharmacology of interferons. I. Pharmacologic distinctions between human leucocyte and fibroblast interferons. Int J Immunopharmacol 1:219–226

    Google Scholar 

  • Heron I, Hokland M Berg K (1978) Enhanced expression of β2 microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci USA 75:6215–6219

    Google Scholar 

  • Hewitt HB (1978) The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res 27:149–200

    Google Scholar 

  • Hirt HM, Becker H, Kirchner H (1978) Induction of interferon production in mouse spleen cell cultures by Corynebacterium parvum Cell Immunol 38:168–175

    Google Scholar 

  • Horning SJ, Levine JF, Miller RA, Merigan TC (1981) Clinical and Immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. Presented at the Second Annual International Congress for Interferon Research. October 21–23, San Francisco, USA

  • Huang KY, Donahoe RM, Gordon FB, Dressler H (1971) Enhancement of phagocytosis by interferon containing preparations. Infect Immun 4:581–588

    Google Scholar 

  • Kirchner H (1981) Logistics of tumor immunology. Klin Wochenschr (in press) Klein G (1973) Tumor immunology. Transplant Proc 5:31–41

    Google Scholar 

  • Lindenmann J (1981) Perspektiven der Interferon-Forschung. Naturwissenschaften 68:9–13

    Google Scholar 

  • Lucero MA, Fridman WH, Prevost MA, Billardon, C, Pouillart P, Dumont J, Falcoff E (1981) Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients. Cancer Res 41:294–299

    Google Scholar 

  • Marcucci F, Waller M, Kirchner H, Krammer P (1981) Production of immune interferon (IFN-γ) by murine T-cell clones from long-term cultures. Nature 291:79–81

    Google Scholar 

  • Munk K, Kirchner H (eds) (1982) Interferon: Properties, mode of action, production and clinical application. Karger Basel (in press)

    Google Scholar 

  • Nagata S, Mantei N, Weissmann Ch (1980) The structure of one of the eight or more distinct chromosomal genes for human interferon. Nature 287:401–408

    Google Scholar 

  • Nathan H, Groopman JE, Quan SG, Bersch N, Golde DW (1981) Immune (γ) interferon produced by a human T-lymphoblast cell line. Nature 292:842–844

    Google Scholar 

  • Newmark P (1981) Nature editorial: Interferon. Decline and stall Nature 291:105–106

    Google Scholar 

  • Scott GM, Secher DS, Flowers D, Bate J, Cantell K, Tyrrell DAJ (1981) Toxicity of interferon. Br Med J 282:1345–1348

    Google Scholar 

  • Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Maramatsu M, Weissmann Ch (1980) Human leucocyte and fibroblast interferon are structurally related. Nature 285:547–549

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Virus Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-6900, Heidelberg, Germany

    H. Kirchner

Authors
  1. H. Kirchner
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest Editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author. The Editors Die Zeitschrift “Journal of Cancer Research and Clinical Oncology” bringt in zwangloser Folge “Editorials” und “Guest Editorials” zu aktuellen und/oder kontroversen Problemen der experimentellen und klinischen Onkologie. Diese Beiträge geben ausschließlich die persönliche Meinung des Autors wieder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirchner, H. Interferons as antitumor agents. J Cancer Res Clin Oncol 103, 1–6 (1982). https://doi.org/10.1007/BF00410300

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00410300

Search

Navigation